» Authors » Alexander Konig

Alexander Konig

Explore the profile of Alexander Konig including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 986
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Largy E, Konig A, Ghosh A, Ghosh D, Benabou S, Rosu F, et al.
Chem Rev . 2021 Sep; 122(8):7720-7839. PMID: 34587741
Nucleic acids have been among the first targets for antitumor drugs and antibiotics. With the unveiling of new biological roles in regulation of gene expression, specific DNA and RNA structures...
22.
Schlotzig V, Kornrumpf K, Konig A, Tucholski T, Hugel J, Overbeck T, et al.
Stud Health Technol Inform . 2021 Sep; 283:209-216. PMID: 34545838
Precision oncology utilizing molecular biomarkers for targeted therapies is one of the hopes to treat cancer. The availability of patient specific molecular profiling through next-generation sequencing, though, increases the amount...
23.
Wessendorf J, Konig A, Heers H, Mahnken A
Cardiovasc Intervent Radiol . 2021 Aug; 44(12):2022-2025. PMID: 34414496
Purpose: Patients with Von Hippel-Lindau disease often develop multifocal, metachronous renal cell carcinomas which require therapy. The purpose of this retrospective single-center study is to evaluate the outcomes of radiofrequency...
24.
Brunner M, Soll D, Adler K, Sasse A, Konig U, Mekolli A, et al.
Gastric Cancer . 2021 Jul; 25(1):161-169. PMID: 34297239
Background: Brain metastases represent a severe complication in many gastrointestinal malignancies especially those arising from the upper gastrointestinal tract, including cancer of the esophagus, gastroesophageal junction, and stomach (GEC). However,...
25.
Yang J, Konig A, Park S, Jo E, Sung P, Yoon S, et al.
JHEP Rep . 2021 Jul; 3(4):100296. PMID: 34222850
Background & Aims: Chronic hepatitis B is an incurable disease. Addressing the unmet medical need for therapies has been hampered by a lack of suitable cell culture models to investigate...
26.
Treiber H, Konig A, Neesse A, Richter A, Sahlmann C, Strauss A
J Nucl Med . 2021 May; 62(7):1016-1019. PMID: 33990402
Lu-PSMA radioligand therapy is a promising new option for patients with metastasized castration-resistant prostate cancer, and the spectrum of adverse events with this treatment has to be evaluated. Here, we...
27.
Li Y, Guo S, Zhao K, Conrad C, Driescher C, Rothbart V, et al.
Biol Chem . 2021 Feb; 402(2):195-206. PMID: 33544472
Glioblastoma multiforme (GBM) is the most aggressive type of brain cancer with a median survival of only 15 months. To complement standard treatments including surgery, radiation and chemotherapy, it is...
28.
Genera M, Quioc-Salomon B, Nourisson A, Colcombet-Cazenave B, Haouz A, Mechaly A, et al.
Sci Rep . 2021 Jan; 11(1):944. PMID: 33441627
Interactions between the hepatitis B virus core protein (HBc) and host cell proteins are poorly understood, although they may be essential for the propagation of the virus and its pathogenicity....
29.
Jo P, Bernhardt M, Nietert M, Konig A, Azizian A, Schirmer M, et al.
PLoS One . 2020 Oct; 15(10):e0239806. PMID: 33002027
Introduction: Oncogenic mutation within the KRAS gene represents a negative predictor for treatment response to anti-epidermal growth factor receptor (EGFR) in patients with colorectal cancer. Recently, we have shown no...
30.
Schleihauf H, Hoehl S, Tsvetkova N, Konig A, Mombaur K, Pauen S
Child Dev . 2020 Aug; 92(1):222-238. PMID: 32856290
From preschool age, humans tend to imitate causally irrelevant actions-they over-imitate. This study investigated whether children over-imitate even when they know a more efficient task solution and whether they imitate...